Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels-Reference-Cited by-同舟云学术

Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels

Published:2013-07-11 Issue:6 Volume:162 Page:819-826
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Potze Wilma¹,Arshad Freeha¹,Adelmeijer Jelle¹,Blokzijl Hans²,van den Berg Arie P.²,Meijers Joost C. M.³,Porte Robert J.⁴,Lisman Ton

Affiliation:

1. Surgical Research Laboratory; University of Groningen; University Medical Centre Groningen; Groningen; The Netherlands

2. Department of Gastroenterology; University of Groningen; University Medical Centre Groningen; Groningen; The Netherlands

3. Department of Experimental Vascular Medicine; Academic Medical Centre; University of Amsterdam; Amsterdam; The Netherlands

4. Section of Hepatobiliary Surgery and Liver Transplantation; Department of Surgery; University of Groningen; University Medical Centre Groningen; Groningen; The Netherlands

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12462/fullpdf

Reference29 articles.

1. Natural anticoagulants can be useful predictors of severity in chronic liver disease;Abdo;Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis,2010

2. Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease;Bajaj;The Journal of Clinical Investigation,1987

3. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis;Bajaj;Proceedings of the National Academy of Sciences of the USA,1990

4. Plasma protein S-antigen (PS:Ag) in selected disease states;Brudasca;Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne,1994

5. Regulation of coagulation by protein S;Castoldi;Current Opinion in Hematology,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo generation of thrombin in patients with liver disease without apparent evidence of activation of the intrinsic or extrinsic pathway of coagulation;Journal of Thrombosis and Haemostasis;2023-08

2. Coagulopathy of liver disease—a pathophysiologic rebalance of hemostasis and thrombosis;Journal of Thrombosis and Haemostasis;2023-08

3. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis;Journal of Hepatology;2022-05

4. Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH;Journal of Thrombosis and Haemostasis;2021-01-06

5. The Connection between Hypercoagulability and Fibrogenesis in Chronic Liver Diseases;Romanian Biotechnological Letters;2020-09-17